GSP Crop Science IPO 2026 | Should You Invest?

Farming today isn’t just about seeds and soil anymore. Even if rainfall is perfect and the soil is fertile, crops still face a long list of enemies: insects that eat leaves, weeds that choke growth, and diseases that can wipe out entire harvests.
 

That’s why modern agriculture quietly depends on crop protection chemicals! 
The insecticides, herbicides and fungicides that farmers spray on fields play a big role in protecting yields and keeping food production stable.
 

This is exactly where GSP Crop Science Limited operates. For over four decades, GSP Crop Science Limited has developed and manufactured crop protection products including insecticides, herbicides, fungicides and plant growth regulators.
 

The company operates across both technical active ingredients and finished formulations used by farmers. Today, it holds 500+ agrochemical product registrations and over 100 patents, reflecting its research-driven approach.
 

Now the company is heading to the public markets with its  ₹400 crore IPO. At a price band of ₹304 - ₹320 per share, the IPO comprises a fresh issue of ₹240 crore and an offer for sale (OFS) of ₹160 crore by existing shareholders.
But the real question for investors is simple: can a mid-sized agrochemical manufacturer turn its research capabilities and product portfolio into consistent long-term growth for shareholders?
 

Let’s break down the business model, financial performance and IPO details to understand whether this opportunity deserves a closer look.

GSP Crop Science Limited is a research-driven agrochemical company with over 40 years of experience, developing and manufacturing crop protection products including insecticides, herbicides, fungicides and plant growth regulators.

The company operates across two key segments: Formulations are finished crop protection products created by combining active ingredients with additives, while technicals are concentrated active ingredients that are either sold to other agrochemical manufacturers or used internally to produce formulations.

As of September 30, 2025, the company held 524 agrochemical product registrations, including 395 registrations for formulations and 129 for technicals. Its product portfolio primarily addresses pest, weed and disease control across crops such as rice, wheat, groundnut and chilli.

As of the Red Herring Prospectus date, the company has been granted 102 patents, with 108 additional patent applications under process. Operationally, GSP Crop Science Limited runs five manufacturing facilities located in Odhav, Kathwada and Nandesari in Gujarat, Samba in Jammu & Kashmir, and Saykha in Dahej.

A key positive is the company’s increasing share of patented products, which has risen to over 17% of revenue, supporting margin expansion. Additionally, backward integration initiatives and the upcoming Dahej facility are expected to reduce dependence on Chinese imports and improve operating leverage over time.

Here are the key details investors should know:

• IPO Size: ₹400 crore
• Price Band: ₹304 - ₹320 per share
• IPO Dates: 16 - 18 March 2026
• IPO Type: Fresh Issue + Offer for Sale (OFS)
• Minimum Investment: ₹14,720 (or 46 shares - lot size)
• Listing Date: 24 March 2026
• Proposed Listing: BSE & NSE
• Lead Manager: Equirus Capital Pvt.Ltd. 

GSP Crop Science Limited’s ₹400 crore IPO is a book-built issue comprising ₹240 crore (60%) fresh issue and ₹160 crore (40%) Offer for Sale. This means a majority of the proceeds will go to the company, while the OFS portion will go to the selling shareholders.
 

As per the company’s Red Herring Prospectus (RHP), the fresh issue proceeds from the IPO will be used for:

• Repayment / prepayment of borrowings: ₹170 crore
• General corporate purposes

The company also notes that funds allocated toward general corporate purposes will not exceed 25% of the gross proceeds from the issue.

GSP Crop Science Limited has reported steady growth in recent years, supported by its formulations-led product mix and domestic distribution network.
 

For the six months ended September 2025, the company reported revenue from operations of ₹847.61 crore. The domestic market accounted for ₹762.85 crore (90%) of revenue, while exports contributed ₹84.76 crore (10%). Product sales are dominated by formulations. During the same period, formulations contributed ₹603.48 crore (71.81%) of product sales, while technicals contributed ₹236.91 crore (28.19%).
 

On the profitability front, the company reported EBITDA of ₹138.86 crore for the six months ended September 2025, translating into an EBITDA margin of around 16.45%. Profit after tax (PAT) stood at ₹81.07 crore, reflecting stable profitability despite raw material cost volatility typical in the agrochemical sector.
 

Innovation also contributes to the revenue mix. Sales from patented products stood at ₹143.68 crore in H1 FY26, accounting for 17.1% of product sales, highlighting the company’s focus on differentiated agrochemical products.
Operationally, the company’s distribution network remains a key growth driver. Its domestic B2C network expanded to 5,644 distributors in FY25, with 4,801 distributors active as of September 2025, enabling wide farmer reach across multiple agricultural regions.
 

However, like most agrochemical businesses, the company operates in a working-capital intensive environment, driven by seasonal demand cycles, inventory requirements and distributor credit cycles.

GSP Crop Science Limited operates in India’s agrochemical industry alongside players like PI Industries Limited, Sumitomo Chemical India Limited, Dhanuka Agritech Limited, Rallis India Limited, Bharat Rasayan Limited, India Pesticides Limited, Excel Industries Limited, and Heranba Industries Limited.
 

At the upper price band of ₹320, and based on an FY25 EPS of ₹34.84, the IPO is valued at roughly 9.19× P/E.
But comparing that number directly with peers can be misleading! 
Companies like PI Industries Limited (around 30× P/E) and Sumitomo Chemical India Limited (about 35× P/E) are ₹50,000+ crore companies. Their higher valuations partly reflect scale, liquidity and strong institutional ownership, not just business quality.
 

A more meaningful comparison is with companies closer to GSP’s size bracket.
In that group, Excel Industries Limited trades at around 14.8× P/E, India Pesticides Limited at roughly 17×, and Bharat Rasayan Limited at about 19×, all companies with market caps under ₹2,500 crore. Against this peer set, GSP’s 9.19× valuation looks broadly fairly priced. 
 

The EV/EBITDA of 11.9×, compared with a peer range of 20x - 55x, stands out at first glance. But part of this discount reflects the company’s ₹479 crore debt burden, something debt-light peers like Dhanuka Agritech Limited don’t carry.

• Regulatory Approval Risk: The company requires product registrations and approvals from authorities such as the Central Insecticides Board and Registration Committee (CIBRC). Failure to obtain or renew these licenses could restrict manufacturing and product sales.

   

• Product Quality & Compliance Risk: Agrochemical products must meet strict technical specifications. Any failure to comply could lead to loss of registrations, customer complaints, or reputational damage. The company also has certain misbranding and product quality litigations pending.

   

• Raw Material & China Dependence Risk: A significant share of raw materials is imported from China, accounting for 42.08% of purchases in H1 FY26. Supply disruptions, import restrictions or price volatility could impact production and margins.

   

• Raw Material Cost Volatility: Raw materials form the largest portion of operating costs. If the company cannot pass on rising input costs to customers, profitability may be affected.

   

• Weather & Agricultural Cycle Risk: Demand for agrochemicals depends heavily on crop cycles and weather conditions. Droughts, floods or adverse monsoon patterns may reduce demand for crop protection products.

   

• Intellectual Property Risk: The company relies on its 102 granted patents (with 108 applications pending) for product differentiation. Any inability to protect these patents could weaken its competitive advantage. 

GSP Crop Science appears well placed for steady long-term growth, supported by rising global demand for agrochemicals, increasing export opportunities, and a gradual shift toward higher-margin products. The company’s growth trajectory is likely to be further strengthened by new product launches, enhanced R&D capabilities, and ongoing backward integration efforts.
 

Additionally, the commissioning of its Dahej manufacturing facility and expansion into international markets are expected to drive volume growth and improve operating leverage over time.
 

At the upper price band of ₹320, the IPO is valued at a P/E of 9.19x based on annualized FY26 earnings (EPS of ₹34.84), which looks reasonable. Considering these factors, we recommend “subscribing” to the issue from a medium-to long-term perspective.

1. What are the IPO dates for the GSP Crop Science Limited IPO?
The IPO of GSP Crop Science Limited opens on March 16, 2026 and closes on March 18, 2026. The shares are proposed to be listed on March 24, 2026 on the BSE and NSE.
 

2. What is the GSP Crop Science IPO GMP?
Grey market activity indicates market interest in the IPO. Check the live GMP for the GSP Crop Science IPO here. (GMPs are unofficial and can change rapidly.)
 

3. What is the lot size for retail investors?
The minimum lot size is 46 shares, which translates to a minimum investment of approximately ₹13,984 - ₹14,720 at the price band.
 

4. Is the GSP Crop Science IPO a fresh issue or an OFS?
The ₹400 crore IPO comprises ₹240 crore (60%) fresh issue and ₹160 crore (40%) Offer for Sale. The fresh issue proceeds will primarily be used for repayment or prepayment of borrowings and general corporate purposes.
 

5. Should I invest in the GSP Crop Science IPO?
Investors seeking exposure to the agrochemical and crop protection sector may find the IPO relevant. However, they should consider risks related to regulatory approvals, dependence on imported raw materials (especially from China), raw material price volatility and weather-linked demand cycles.
 

6. What drives growth for GSP Crop Science?
Growth is linked to agricultural productivity trends, demand for crop protection chemicals and expansion into export markets. The company’s 500+ product registrations, patent portfolio and large domestic distribution network also support long-term growth potential.